Status:
COMPLETED
Administration of Ketamine to Prevent the Post-operative Pain
Lead Sponsor:
Institut Bergonié
Conditions:
Postoperative Pain
Breast Cancer
Eligibility:
FEMALE
18-100 years
Phase:
PHASE3
Brief Summary
The surgery of breast cancer is responsible for post-operative pain, needing in about 30% some morphine consumption; like that, the association of ketamine with general anaesthesia may decrease morphi...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients 18 years older
- ASA class 1 or 2
- with surgery of breast cancer (mastectomy or tumorectomy)
- Exclusion criteria:
- .Kétamine hypersensitivity
- Major psychiatric disorders
- Major cardio-vascular disorders
- Major neurologic disorders
- Major ocular disorders
- Morphine in pre-operative period
Exclusion
Key Trial Info
Start Date :
January 31 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2005
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT00210210
Start Date
January 31 2004
End Date
December 31 2005
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest
Bordeaux, France, 33076